Administer Abacavir, Dolutegravir, and Lamivudine tablets by mouth, with or without meals.
Avoid crushing or chewing the tablet; instead, ingest it whole.
For suspension tablets, adhere to the guidelines provided on their packaging.
Triumeq®, Triumeq PD®
Avoid crushing or chewing the tablet; instead, ingest it whole.
For suspension tablets, adhere to the guidelines provided on their packaging.
When it is not to be taken (Contraindications)
- Contraindicated in patients with known allergies to Abacavir, Dolutegravir and Lamivudine.
- Abacavir, Dolutegravir and Lamivudine may interact with other medications. Consult with your doctor to avoid any interaction related side effects.
- Contraindicated in patients with a history of liver disease, heart disease, or kidney disease.
- If you are pregnant or breastfeeding, avoid taking this medication.
- This medication is not recommended for children younger than 3 months and less than 6kg in body weight.
What if you Miss a Dose of Abacavir, Dolutegravir and Lamivudine?
If a dose is missed, it's advisable to forego it and proceed with the next scheduled dose properly. Doubling up on the dose should be avoided.Drug Name : Abacavir, Dolutegravir and Lamivudine
Abacavir, Dolutegravir,and Lamivudine combination tablets are prescribed to HIV-infected patients.Trade Names/Brand Names of Abacavir, Dolutegravir and Lamivudine
International :
Triumeq®, Triumeq PD®
